1月19日消息，汇仁肾宝的母公司汇仁药业近期的IPO引起不小的关注，因环保问题被举报、产品缺陷等“黑历史”也被一一挖出来。拨开这些“招黑”素材，亿邦动力网还从汇仁药业的招股书中了解到其电商业务的重要信息。招股书显示，此次汇仁药业将募集约19.8亿元，用于主营业务相关的项目，包括中成药生产线及仓储建设项目（投入约9.86亿元）、品牌营销及渠道网络建设项目（投入约4.47亿元）、医药研发项目（投入4亿元）、信息化建设技改项目（投入1.5亿元）。值得注意的是，在汇仁的品牌营销及渠道网络建设项目中，明确包含了电子商务平台项目。根据招股书披露的信息，汇仁药业将投入4907万元用于自建电商平台，占其品牌营...
January 19, the parent of renal bao hui ren hui ren pharmaceutical recent IPO a lot of attention, because of environmental problem is reported, the product defects such as "black history" has also been dig out one by one. Through these "recruit black" material, hundred million bond power network is from the prospectus of hui ren pharmaceutical understands the importance of the electricity business information. Prospectus shows that the hui ren pharmaceutical will raise about $1.98 billion, used for main business related projects, including proprietary Chinese medicine production line and warehouse construction project (invested about 986 million yuan), brand marketing and channel construction projects (spent about 447 million yuan), pharmaceutical research and development project investment of 400 million yuan (), information construction technical renovation project investment of 150 million yuan (). It is worth noting that in hui ren brand marketing channel construction projects, and specifically includes e-commerce platform project. According to the prospectus disclosure of information, hui ren pharmaceutical industry will invest 49.07 million yuan to build electric business platform, make its brand camp...
